Obra Publicada
Selecció:
- Ruiz-Plazas, X.; Altuna-Coy, A.; Alves-Santiago, M.; Vila-Barja, J.; et al. Liquid Biopsy-Based Exo-oncomiRNAs Can Predict Prostate Cancer Aggressiveness. Cancers (Basel). 2021 Jan 11;13(2):250.
- Centeno Álvarez, C.; Ascaso Til, H.; Argilés Mattes, N.; Fabia Mayans, A.; Vila Barja, J.; Segarra Tomás, J. Nonischemic priapism: Diagnostic and therapeutic options. Arch Esp Urol. 2017 Oct;70(8):746-747.
- Reig Ruiz, C.; Vallejo Gil, C.; Lorente Garín, JA.; Vila Barja, J.; et. al. [A vesicoileal fistula secondary to bladder cancer]. Actas Urol Esp. 1994 May;18(5):615-8.
- García Rojo, D.; Vicente Palacio, E.; Calvo Mateo, MA.; Vila Barja J.; et. al. [Intravesical foreign body. Post-traumatic migration of autologous bone fragment]. Arch Esp Urol. 1993 Dec;46(10):905-7.
- Reig Ruiz, C.; Vila Barja, J.; Quintanilla Muñoz, B.; et. al. [Appendico-vesical fistula secondary to acute appendicitis. Review of the literature]. Arch Esp Urol. 1993 May;46(4):340-2.
- Morote Robles, J.; Reig Ruiz, C.; Vila Barja, J.; et. al. [Impact of specific prostatic antigen on the rationalization of the use of bone gammagraphies in the follow-up of hormone-treated non- metastatic prostatic cancer]. Actas Urol Esp. 1993 May;17(5):292-4.
- Morote Robles, J.; Reig Ruiz, C.; Vila Barja, J.; et. al. [Does transurethral resection cause metastatic dissemination of hormone treated prostatic cancer?]. Actas Urol Esp. 1993 Mar;17(3):187-9.
- Reig Ruiz, C.; Tremps Velázquez, E.; Margarit Creixell, C.; Vila Barja J.; et. al. [Wunderlich syndrome secondary to the rupture of an aneurysm of the renal artery. Review of the literature]. Arch Esp Urol. 1992 Jun;45(5):417-20.
- Morote Robles, J.; Vila Barja J.; et. al. [Complete hormonal blockade vs. monotherapy in the management of metastasizing prostatic cancer]. Actas Urol Esp. 1992 Jun;16(6):451-4.
- Reig Ruiz, C.; Vila Barja, J.; et. al. [Infrequent cause of bilateral obstructive uropathy]. Actas Urol Esp. 1992 May;16(5):420-1.
- Morote Robles, J.; Vila Barja, J.; et. al. [Medical treatment of benign prostatic hyperplasia in patients with high surgical risk]. Actas Urol Esp. 1992 May;16(5):417-9.
- Morote Robles, J.; Vila Barja, J.; et. al. [Value of prostate-specific antigen as prognostic factor of metastatic cancer of the prostate]. Actas Urol Esp. 1992 May;16(5):394-7.